PURPOSE: To assess the diagnostic validity of a fully automated image analysis algorithm of in vivo confocal microscopy images in quantifying corneal subbasal nerves to diagnose diabetic neuropathy. METHODS: One hundred eighty-six patients with type 1 and type 2 diabetes mellitus (T1/T2DM) and 55 age-matched controls underwent assessment of neuropathy and bilateral in vivo corneal confocal microscopy (IVCCM). Corneal nerve fiber density (CNFD), branch density (CNBD), and length (CNFL) were quantified with expert, manual, and fully-automated analysis. The areas under the curve (AUC), odds ratios (OR), and optimal thresholds to rule out neuropathy were estimated for both analysis methods. RESULTS: Neuropathy was detected in 53% of patients with diabetes. A significant reduction in manual and automated CNBD (P < 0.001) and CNFD (P < 0.0001), and CNFL (P < 0.0001) occurred with increasing neuropathic severity. Manual and automated analysis methods were highly correlated for CNFD (r = 0.9, P < 0.0001), CNFL (r = 0.89, P < 0.0001), and CNBD (r = 0.75, P < 0.0001). Manual CNFD and automated CNFL were associated with the highest AUC, sensitivity/specificity and OR to rule out neuropathy. CONCLUSIONS: Diabetic peripheral neuropathy is associated with significant corneal nerve loss detected with IVCCM. Fully automated corneal nerve quantification provides an objective and reproducible means to detect human diabetic neuropathy.
PURPOSE: To assess the diagnostic validity of a fully automated image analysis algorithm of in vivo confocal microscopy images in quantifying corneal subbasal nerves to diagnose diabetic neuropathy. METHODS: One hundred eighty-six patients with type 1 and type 2 diabetes mellitus (T1/T2DM) and 55 age-matched controls underwent assessment of neuropathy and bilateral in vivo corneal confocal microscopy (IVCCM). Corneal nerve fiber density (CNFD), branch density (CNBD), and length (CNFL) were quantified with expert, manual, and fully-automated analysis. The areas under the curve (AUC), odds ratios (OR), and optimal thresholds to rule out neuropathy were estimated for both analysis methods. RESULTS:Neuropathy was detected in 53% of patients with diabetes. A significant reduction in manual and automated CNBD (P < 0.001) and CNFD (P < 0.0001), and CNFL (P < 0.0001) occurred with increasing neuropathic severity. Manual and automated analysis methods were highly correlated for CNFD (r = 0.9, P < 0.0001), CNFL (r = 0.89, P < 0.0001), and CNBD (r = 0.75, P < 0.0001). Manual CNFD and automated CNFL were associated with the highest AUC, sensitivity/specificity and OR to rule out neuropathy. CONCLUSIONS:Diabetic peripheral neuropathy is associated with significant corneal nerve loss detected with IVCCM. Fully automated corneal nerve quantification provides an objective and reproducible means to detect humandiabetic neuropathy.
Authors: Nathan Efron; Katie Edwards; Nicola Roper; Nicola Pritchard; Geoff P Sampson; Ayda M Shahidi; Dimitrios Vagenas; Anthony Russell; Jim Graham; Mohammad A Dabbah; Rayaz A Malik Journal: Eye Contact Lens Date: 2010-09 Impact factor: 2.018
Authors: R A Malik; P Kallinikos; C A Abbott; C H M van Schie; P Morgan; N Efron; A J M Boulton Journal: Diabetologia Date: 2003-05-09 Impact factor: 10.122
Authors: Mitra Tavakoli; Cristian Quattrini; Caroline Abbott; Panagiotis Kallinikos; Andrew Marshall; Joanne Finnigan; Philip Morgan; Nathan Efron; Andrew J M Boulton; Rayaz A Malik Journal: Diabetes Care Date: 2010-04-30 Impact factor: 19.112
Authors: P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service Journal: Neurology Date: 1993-04 Impact factor: 9.910
Authors: Ioannis N Petropoulos; Uazman Alam; Hassan Fadavi; Omar Asghar; Patrick Green; Georgios Ponirakis; Andrew Marshall; Andrew J M Boulton; Mitra Tavakoli; Rayaz A Malik Journal: Diabetes Care Date: 2013-07-22 Impact factor: 19.112
Authors: Xin Chen; Jim Graham; Mohammad A Dabbah; Ioannis N Petropoulos; Georgios Ponirakis; Omar Asghar; Uazman Alam; Andrew Marshall; Hassan Fadavi; Maryam Ferdousi; Shazli Azmi; Mitra Tavakoli; Nathan Efron; Maria Jeziorska; Rayaz A Malik Journal: Diabetes Care Date: 2015-03-20 Impact factor: 19.112
Authors: B S Kowtharapu; K Winter; C Marfurt; S Allgeier; B Köhler; M Hovakimyan; T Stahnke; A Wree; O Stachs; R F Guthoff Journal: Eye (Lond) Date: 2016-11-04 Impact factor: 3.775
Authors: Michael Brines; Ann N Dunne; Monique van Velzen; Paolo L Proto; Claes-Goran Ostenson; Rita I Kirk; Ioannis N Petropoulos; Saad Javed; Rayaz A Malik; Anthony Cerami; Albert Dahan Journal: Mol Med Date: 2015-03-13 Impact factor: 6.354
Authors: Xin Chen; Jim Graham; Mohammad A Dabbah; Ioannis N Petropoulos; Mitra Tavakoli; Rayaz A Malik Journal: IEEE Trans Biomed Eng Date: 2016-06-07 Impact factor: 4.538